|
1
|
Zheng R, Zeng H, Zhang S, Fan Y, Qiao Y,
Zhou Q and Chen W: Lung cancer incidence and mortality in China,
2010. Thorac Cancer. 5:330–336. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schwartz AM and Rezaei MK: Diagnostic
surgical pathology in lung cancer: Diagnosis and management of lung
cancer, 3rd ed: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest. 143 (Suppl 5):Se251–Se262.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Collins LG, Haines C, Perkel R and Enck
RE: Lung cancer: Diagnosis and management. Am Fam Physician.
75:56–63. 2007.PubMed/NCBI
|
|
5
|
Goldstraw P, Ball D, Jett JR, Le Chevalier
T, Lim E, Nicholson AG and Shepherd FA: Non-small-cell lung cancer.
Lancet. 378:1727–1740. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fennell DA, Summers Y, Cadranel J, Benepal
T, Christoph DC, Lal R, Das M, Maxwell F, Visseren-Grul C and Ferry
D: Cisplatin in the modern era: The backbone of first-line
chemotherapy for non-small cell lung cancer. Cancer Treat Rev.
44:42–50. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Amable L: Cisplatin resistance and
opportunities for precision medicine. Pharmacol Res. 106:27–36.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Holford J, Sharp SY, Murrer BA, Abrams M
and Kelland LR: In vitro circumvention of cisplatin resistance by
the novel sterically hindered platinum complex AMD473. Br J Cancer.
77:366–373. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Averett C, Arora S, Zubair H, Singh S,
Bhardwaj A and Singh AP: Molecular targets of Honokiol: A promising
phytochemical for effective cancer management. Enzymes. 36:175–193.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Park E, Min H, Chung H, Hong J, Kang Y,
Hung T, Youn U, Kim Y, Bae K, Kang S and Lee S: Down-regulation of
c-Src/EGFR-mediated signaling activation is involved in the
honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231
human breast cancer cells. Cancer Lett. 277:133–140.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fan Y, Xue W, Schachner M and Zhao W:
Honokiol eliminates glioma/glioblastoma stem cell-like cells via
JAK-STAT3 signaling and inhibits tumor progression by targeting
epidermal growth factor receptor. Cancers (Basel).
11(22)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sengupta S, Nagalingam A, Muniraj N,
Bonner MY, Mistriotis P, Afthinos A, Kuppusamy P, Lanoue D, Cho S,
Korangath P, et al: Activation of tumor suppressor LKB1 by honokiol
abrogates cancer stem-like phenotype in breast cancer via
inhibition of oncogenic Stat3. Oncogene. 36:5709–5721.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu H, Yin Z, Wang L, Li F and Qiu Y:
Honokiol improved chondrogenesis and suppressed inflammation in
human umbilical cord derived mesenchymal stem cells via blocking
nuclear factor-κB pathway. BMC Cell Biol. 18(29)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li Y and Zhang T: Targeting cancer stem
cells by curcumin and clinical applications. Cancer Lett.
346:197–205. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheng Q, Liao M, Hu H, Li H and Wu L:
Asiatic acid (AA) sensitizes multidrug-resistant human lung
adenocarcinoma A549/DDP cells to cisplatin (DDP) via downregulation
of P-Glycoprotein (MDR1) and its targets. Cell Physiol Biochem.
47:279–292. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen LP, Wang P, Sun YJ and Wu YJ: Direct
interaction of avermectin with epidermal growth factor receptor
mediates the penetration resistance in Drosophila larvae. Open
Biol. 6(150231)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W,
De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes
to cisplatin resistance of human lung adenocarcinoma cells via
downregualtion of p21WAF1/CIP1 expression. PLoS One.
8:e77293–e77303. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lin Y, Duan Q and Yang YP:
Immunohistochemistry of phosphatase and tensin homolog and
metalloproteinase-9 in breast invasive micropapillary carcinoma.
Eur J Gynaecol Oncol. 40:380–383. 2019.
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dong Z, Ren L, Lin L and Li J, Huang Y and
Li J: Effect of microRNA-21 on multidrug resistance reversal in
A549/DDP human lung cancer cells. Mol Med Rep. 11:682–690.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu D, Lu Q and Hu X: Down-regulation of
P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by
honokiol. Cancer Lett. 243:274–280. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ishitsuka K, Hideshima T, Hamasaki M, Raje
N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM,
Richardson P, et al: Honokiol overcomes conventional drug
resistance in human multiple myeloma by induction of
caspase-dependent and -independent apoptosis. Blood. 106:1794–1800.
2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee S, Khoo C, Halstead CW, Huynh T and
Bensoussan A: Liquid chromatographic determination of honokiol and
magnolol in hou po (Magnolia officinalis) as the raw herb
and dried aqueous extract. J AOAC Int. 90:1210–1218.
2019.PubMed/NCBI
|
|
24
|
Chio CC, Chen KY, Chang CK, Chuang JY, Liu
CC, Liu SH and Chen RM: Improved effects of honokiol on
temozolomide-induced autophagy and apoptosis of drug-sensitive and
-tolerant glioma cells. BMC Cancer. 18(379)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li W, Wang Q, Su Q, Ma D, An C, Ma L and
Liang H: Honokiol suppresses renal cancer cells' metastasis via
dual-blocking epithelial-mesenchymal transition and cancer stem
cell properties through modulating miR-141/ZEB2 signaling. Mol
Cells. 37:383–388. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yao C, Lai G, Yeh C, Lai M, Shih P, Chao
W, Whang-Peng J, Chuang S and Lai T: Honokiol eliminates human oral
cancer stem-like cells accompanied with suppression of
Wnt/β-catenin signaling and apoptosis induction. Evid Based
Complement Alternat Med. 2013(146136)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wynn M, Consul N, Merajver S and Schnell
S: Inferring the effects of honokiol on the notch signaling pathway
in SW480 colon cancer cells. Cancer Inform. 13 (Suppl 5):S1–S12.
2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lai I, Shih P, Yao C, Yeh C, Wang-Peng J,
Lui T, Chuang S, Hu T, Lai T and Lai G: Elimination of cancer
stem-like cells and potentiation of temozolomide sensitivity by
Honokiol in glioblastoma multiforme cells. PLoS One.
10(e0114830)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ye M and Zhang J and Zhang J, Miao Q, Yao
L and Zhang J: Curcumin promotes apoptosis by activating the
p53-miR-1922-5p/215-XIAP pathway in non-small cell lung cancer.
Cancer Lett. 357:196–205. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lv L, Qiu K, Yu X, Chen C, Qin F, Shi Y,
Ou J, Zhang T, Zhu H, Wu J, et al: Amphiphilic copolymeric micelles
for doxorubicin and curcumin co-delivery to reverse multidrug
resistance in breast cancer. J Biomed Nanotechnol. 12:973–985.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yuan HB, Meng PY and Qi LJ: Curcumin
up-regulates miR-133a expression to inhibit hepatocellular
carcinoma cell migration and invasion. World Chinese J Digestol,
2019.
|
|
32
|
Hosseini A, Rasmi Y, Rahbarghazi R,
Aramwit P, Daeihassani B and Saboory E: Curcumin modulates the
angiogenic potential of human endothelial cells via FAK/P-38 MAPK
signaling pathway. Gene. 688:7–12. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Almanaa T, Geusz M and Jamasbi R: Effects
of curcumin on stem-like cells in human esophageal squamous
carcinoma cell lines. BMC Complement Altern Med.
12(195)2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang Y, Lin Y, Chiu H and Chiang B:
Curcumin induces apoptosis of colorectal cancer stem cells by
coupling with CD44 marker. J Agric Food Chem. 64:2247–2253.
2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mukherjee S, Mazumdar M, Chakraborty S,
Manna A, Saha S, Khan P, Bhattacharjee P, Guha D, Adhikary A,
Mukhjerjee S and Das T: Curcumin inhibits breast cancer stem cell
migration by amplifying the E-cadherin/β-catenin negative feedback
loop. Stem Cell Res Ther. 5(116)2014.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Wilkens S: Structure and mechanism of ABC
transporters. F1000Prime Rep. 7(14)2015.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Liu CH, Huang Q, Jin ZY, Zhu CL, Liu Z and
Wang C: miR-21 and KLF4 jointly augment epithelial-mesenchymal
transition via the Akt/ERK1/2 pathway. Int J Oncol. 50:1109–1115.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhang S, Bian H, Li X, Wu H, Bi Q, Yan Y
and Wang Y: Hydrogen sulfide promotes cell proliferation of oral
cancer through activation of the COX2/AKT/ERK1/2 axis. Oncol Rep.
35:2825–2832. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Krebs K, Ruusmann A, Simonlatser G and
Velling T: Expression of FLNa in human melanoma cells regulates the
function of integrin α1β1 and phosphorylation and localisation of
PKB/AKT/ERK1/2 kinases. Eur J Cell Biol. 94:564–575.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hu Y, Hong Y, Xu Y, Liu P, Guo DH and Chen
Y: Inhibition of the JAK/STAT pathway with ruxolitinib overcomes
cisplatin resistance in non-small-cell lung cancer NSCLC.
Apoptosis. 19:1627–1636. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang
D, Chen Z, Yang D, Xu Z and Yu Z: Combination of gambogic acid with
cisplatin enhances the antitumor effects on cisplatin-resistant
lung cancer cells by downregulating MRP2 and LRP expression. Onco
Targets Ther. 9:3359–3368. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Dai M, Alodaini AA, Filsaimé N, Villatoro
MA, Guo J, Arakelian A, Rabbani SA, Ali S and Lebrun JJ: Cyclin D1
cooperates with p21 to regulate TGFβ-mediated breast cancer cell
migration and tumor local invasion. Breast Cancer Res.
15(3246)2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Giganti Μg, Tresoldi I, Sorge R,
Melchiorri G, Triossi T, Masuelli L, Lido P, Albonici L, Foti C,
Modesti A and Bei R: Physical exercise modulates the level of serum
MMP-2 and MMP-9 in patients with breast cancer. Oncol Lett.
12:2119–2126. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Jayakumar T, Liu CH, Wu GY, Lee TY,
Manubolu M, Hsieh CY, Yang CH and Sheu JR: Hinokitiol inhibits
migration of A549 lung cancer cells via Suppression of MMPs and
induction of antioxidant enzymes and apoptosis. Int J Mol Sci.
19(939)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Laskowska M: Altered maternal serum matrix
metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in severe early-
and late-onset preeclampsia. Biomed Res Int.
2017(6432426)2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen J, Ren Z, Zhu M and Khalil RA:
Decreased homodimerization and increased TIMP-1 complexation of
uteroplacental and uterine arterial matrix metalloproteinase-9
during hypertension-in-pregnancy. Biochem Pharmacol. 138:81–95.
2017.PubMed/NCBI View Article : Google Scholar
|
